EUROPEAN LEGISLATION REQUIRES ENDOCRINE POTENTIAL ASSESSMENT
As part of the authorisation procedure for biocidal substances and products (Commission Delegated Regulation (EU) 2017/2100) and plant protection products (Commission Regulation (EU) 2018/605), assessment of endocrine properties of the substances in the product must be prepared according to the Guidelines for the determination of endocrine-disrupting properties.
Scope of the endocrine potential assessment
As part of the endocrine potential assessment, we prepare the following:
At this stage, we make a scientific review of the existing evidence by collecting all available scientific studies conducted in accordance with the agreed protocols. The studies will be collected from the existing databases, and additional in-silico analyses will be carried out if necessary.
Assessment of evidence
We evaluate the collected information according to the requirements of the guidelines, and prepare a summary of the studies.
We prepare a report in accordance with the requirements of the regulators as to whether the criteria for endocrine-disrupting properties related to human health and non-target organisms have been met, and propose a testing plan if necessary.